Proposal for ROCR Approval
1. Record
Type?
New
2. Unique
Number
R01096
3. Title
Monthly automated vaccine coverage collections
4. Collection
Type
National
5. Other
Reference
6. Description
PHE is responsible for central aggregated vaccine coverage data coll
immunisation programmes. Accurate collection and reporting of rout
immunisation programmes as described under the terms of the sect
support it. Vaccine coverage data is also used to plan public health r
further interventions and helps inform future vaccine policy decision
three recently introduced vaccination programmes: i) routine rotavir
shingles programme (started September 2013) iii) selective pre-nat
these collections are automatically extracted from GP IT systems an
used by PHE to record vaccine coverage data for some immunisation
NHS, and can be accessed by NHS England local teams for performa
nationally for the evaluation of the programmes and reporting to De
7. State
Ready for Panels
8. ROCR
Reference No
9. Start Date
01/04/2015
10. End Date
31/03/2018
11. FT
Collection
Type
NOT REQUIRED
Proposal for ROCR Approval
12. Collection
Type
MANDATORY
13. Owning
Organisation
Public Health England
14. Owning
Department
Immunisation
15. Owner
Name and
Contact
Details
Name: Joanne White
Email: joanne.white@phe.gov.uk
Tel No: 02083277446
Location: Immunisation, Hepatitis and Blood Safety Department, Ce
Health England, 61 Colindale Avenue, LONDON
16. Senior
Supporting
Official Name
Dr Mary Ramsay
17. Senior
Supporting
Official
Contact
Details
Title: Consultant Epidemiologist and Head of Immunisation, Hepatiti
18. Data
Provider Burden Days
0
18. Data
Provider Burden £
£0
18.
Frequency
Monthly
Location: Immunisation, Hepatitis and Blood Safety Department, Ce
Health England, 61 Colindale Avenue, LONDON
Proposal for ROCR Approval
18. Source
Organisations
(Number of
orgs)
GP Practice (7810)
19. Set Up
Costs
£0
20. Other
Costs
£ 151571
21. Total
Costs
£ 151571
22. Please
explain the
reason for
any increase
or decrease
in burden and
provide
details of the
any other
costs figure
provided in
Q20
There is no burden for these collections for the source organisations
permission to participate in the collections survey data are automati
to the ImmForm website in line with agreed survey-specific timetabl
work, project management and development and testing of the Imm
to develop and test a new clinical specification for a collection with G
surveys where appropriate; Staff costs (admin/scientific/medical)
23. Benefits
to Patients
and the NHS
The ability to reliably measure vaccine coverage plays an essential r
identifying susceptible populations for further interventions and infor
an accurate estimate for the eligible population (denominator) and a
individuals who have received a particular vaccine dose (numerator)
systems in England monitor immunisation coverage data for selectiv
gender and ethnicity are available for most surveys. This information
improve coverage, to detect inequalities and changes in vaccine cov
have been given in a timely manner and promotes equal access to c
These data are also used by the MHRA and in combination with data
24. Financial
benefits to
Maintaining high vaccine coverage in all areas will prevent outbreaks
burden. The financial benefits from a societal perspective include the
Proposal for ROCR Approval
running this
collection
gained, and from an NHS perspective include savings to the NHS su
25.
Publication
methods
Reports and local level data are published on the PHE website data
26.
Publication
Links
https://www.gov.uk/government/collections/vaccine-uptake
27.
Requesting
Organisation
Public Health England
28. Collection
Method
Web based collection
29. NHS
Mandate
Commitment
Monitoring of the national immunisation programmes is mandated u
service specifications that support it
30. Changes
since last
assessment
31. Data in
operational
systems
Yes
32. Plans for
collecting this
data from
operational
systems
PHE has an established work programme for vaccine coverage collec
system suppliers on automated data extractions that are uploaded o
33. If the
data was not
collected,
It would not be possible to monitor new and/or selective vaccination
identify susceptible populations for further interventions and inform
Proposal for ROCR Approval
what would
the
consequences
be
34. Is there
an impact
assessment
or business
case for this
collection? If
so please
attach
35. Process
required for
others to go
through to
obtain the
data
Data are published in excel or tabular format on PHE website where
time by NHS England local teams for performance management of th
36. Keywords
coverage, vaccine, immunisation
37. National /
Official
statistic
NA
38. Method
used to store
the data
39. Why
sampling is
not used
Vaccine coverage is required to be monitored by every area of the c
outbreaks of vaccine preventable disease could occur
40. Details of
any pilots
Surveys based on previous experience of using web based ImmForm
41. Equalities
Age/Date of Birth, Gender, Ethnicity (NHS standard 16 + 1)
Proposal for ROCR Approval
dimensions
used in the
collection
42. Policy
that the
collection
supports
National immunisation programmes are routinely reviewed and revis
meetings of the Joint Committee on Vaccination and Immunisation (
consideration of scientific and other evidence, used by DH to inform,
https://www.gov.uk/government/uploads/system/uploads/attachme
Minutes Jun 2014 meeting (Pre-natal pertussis) https://www.gov.uk
immunisation#minutes; https://www.gov.uk/government/publicatio
43. IG Data
type
Aggregate